MULTI-EPITOPE DNA VACCINE TARGETING CANCER NEOANTIGENS ENHANCES EFFICACY OF ANTI-PD1 THERAPY

被引：0
|
作者：
Bhojnagarwala, Pratik [1 ]
Perales-Puchalt, Alfredo [2 ]
Gary, Ebony [1 ]
Sardesai, Niranjan [2 ]
Weiner, David [1 ]
机构：
[1] Wistar Inst Anat & Biol, Philadelphia, PA USA
[2] Geneos Therapeut, Philadelphia, PA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
PEMBROLIZUMAB; IPILIMUMAB;
D O I：
10.1136/jitc-2022-SITC2022.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1174
引用
收藏
页码：A1217 / A1217
页数：1
相关论文
共 32 条
  • [31] JS']JS001, an anti-PD-1 mAb for advanced triple negative breast cancer patients after multi-line systemic therapy in a phase I trial
    Bian, Li
    Zhang, Huiqiang
    Wang, Tao
    Zhang, Shaohua
    Song, Haifeng
    Xu, Mingli
    Yao, Sheng
    Jiang, Zefei
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
  • [32] Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Matsumoto, Yuji
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Watanabe, Shun-ichi
    Ohe, Yuichiro
    Motoi, Noriko
    EUROPEAN JOURNAL OF CANCER, 2020, 140 : 28 - 36
1234